ClinicalTrials.Veeva

Menu
U

University of Pisa | Department of Dermatology

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Dopamine
sulphonylurea
Dapagliflozin
Linsitinib
Zimura
Troriluzole
Phthalates
OM-85
Thyrogen
Saxagliptin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 41 total trials

A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) (LIDS)

The overall objective is to study the safety, pharmacokinetics and efficacy of linsitinib (a small molecule IGF-1R inhibitor) administered orally twi...

Active, not recruiting
Thyroid Diseases
Graves Ophthalmopathy
Drug: Placebo
Drug: Linsitinib

The goal of this study is to determine if treatment with TCD601 improves beta-cell function in adults recently diagnosed with type 1 diabetes compare...

Active, not recruiting
Diabetes Mellitus, Type 1
Other: Placebo
Biological: TCD601

The study's purpose its to evaluate the efficacy and safety of troriluzole as adjunctive therapy compared to placebo in subjects with Obsessive Compu...

Enrolling
Obsessive-Compulsive Disorder
Drug: Troriluzole
Drug: Placebo

The purpose of the study is to evaluate the long term safety and tolerability of troriluzole as adjunctive therapy in subjects with obsessive compuls...

Invitation-only
Obsessive Compulsive Disorder
Drug: Troriluzole (BHV-4157)

This study will assess the efficacy and safety of OM-85 compared to placebo in reducing the number of respiratory tract infections (RTIs) in children...

Enrolling
Wheezing Lower Respiratory Illness
Respiratory Tract Infections
Drug: Placebo
Drug: OM-85

This is a double-masked, randomized, parallel-assignment, multicenter trial examining the safety and tolerability of teprotumumab in the treatment of...

Active, not recruiting
Thyroid Eye Disease
Drug: Teprotumumab
Drug: Placebo

Trial sponsors

U
Biohaven logo
S
F
Amgen logo
AngioDynamics logo
A
Boston Scientific logo
E
Genzyme logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems